NCT07725926

Brief Summary

Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with concurrent obsessive-compulsive and tic symptoms. Existing psychological interventions typically target one condition or the other, but rarely both together. This study aims to test whether a combined psychological therapy integrating Exposure and Response Prevention (ERP) and Habit Reversal (HbRT) is more effective at reducing symptoms than either therapy delivered alone, in adults with TOCD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
42mo left

Started Jul 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jul 2026Feb 2030

Study Start

First participant enrolled

July 8, 2026

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2030

Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

1.1 years

First QC Date

July 21, 2026

Last Update Submit

July 23, 2026

Conditions

Keywords

Obsessive-Compulsive DisorderTic DisordersTourette SyndromeTourettic Obsessive-Compulsive DisorderExposure and Response PreventionHabit Reversal Training

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Yale-Brown Obsessive Compulsive Scale Total Score

    Obsessive-compulsive symptom severity will be assessed using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Total scores range from 0 to 40, with higher scores indicating greater obsessive-compulsive symptom severity. Change from baseline will be assessed at Week 12 and Week 24.

    Baseline, Week 12 and Week 24

  • Change From Baseline in Yale Global Tic Severity Scale Total Tic Severity Score

    Tic symptom severity will be assessed using the Yale Global Tic Severity Scale (YGTSS) Total Tic Severity Score. Scores range from 0 to 50, with higher scores indicating greater tic symptom severity. Change from baseline will be assessed at Week 12 and Week 24.

    Baseline, Week 12 and Week 24

Secondary Outcomes (1)

  • Change From Baseline in Yale Global Tic Severity Scale Global Severity Score

    Baseline, Week 12 and Week 24

Study Arms (4)

Combined Exposure and Response Prevention and Habit Reversal

EXPERIMENTAL

Participants allocated to this arm will receive a 12-week individual psychological intervention integrating Exposure and Response Prevention (ERP) and Habit Reversal Training (HRT). ERP will involve planned exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while reducing compulsions, avoidance, reassurance seeking, and other safety behaviours. HRT will include awareness training, identification of premonitory urges and tic-related cues, development and practice of competing responses, and strategies to support generalisation. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

Behavioral: Exposure and Response Prevention (ERP)Behavioral: Habit Reversal Training (HbRT

Standardised Exposure and Response Prevention

ACTIVE COMPARATOR

Participants allocated to this arm will receive a 12-week individual psychological intervention based on Exposure and Response Prevention (ERP). Treatment will involve gradual and systematic exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while refraining from compulsions, avoidance, reassurance seeking, and other safety behaviours. The intervention aims to reduce obsessive-compulsive symptoms by promoting inhibitory learning and increasing tolerance of uncertainty and internal experiences. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

Behavioral: Exposure and Response Prevention (ERP)

Standardised Habit Reversal

ACTIVE COMPARATOR

Participants allocated to this arm will receive a 12-week individual psychological intervention based on Habit Reversal Training (HbRT). Treatment will include awareness training to improve recognition of tics and premonitory urges, identification of antecedents and contextual triggers, development and practice of competing responses, and strategies to promote generalisation of skills to everyday settings. The intervention aims to reduce tic severity and improve voluntary tic management. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

Behavioral: Habit Reversal Training (HbRT

Psychoeducation / Supportive Intervention

ACTIVE COMPARATOR

Participants allocated to this arm will receive a 12-week individual psychological intervention consisting of psychoeducation and supportive therapy. Sessions will provide information about obsessive-compulsive disorder, tic disorders, Tourettic obsessive-compulsive disorder, stress, and wellbeing, together with supportive discussion and general problem-solving. This intervention will not include structured Exposure and Response Prevention, Habit Reversal Training, or other targeted behavioural techniques. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

Behavioral: Psychoeducation and Supportive Intervention

Interventions

Exposure and Response Prevention (ERP) is a behavioural intervention that involves gradual and systematic exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while refraining from compulsions, avoidance, reassurance seeking, and other safety behaviours. Treatment is delivered individually over 12 weekly 50-minute sessions, either face-to-face or remotely.

Combined Exposure and Response Prevention and Habit ReversalStandardised Exposure and Response Prevention

Habit Reversal Training (HbRT) is a behavioural intervention that includes awareness training, identification of premonitory urges and antecedents to tic expression, development and practice of competing responses, and strategies to generalise skills across settings. Treatment is delivered individually over 12 weekly 50-minute sessions, either face-to-face or remotely.

Combined Exposure and Response Prevention and Habit ReversalStandardised Habit Reversal

Psychoeducation and Supportive Therapy consists of structured education about obsessive-compulsive disorder, tic disorders, Tourettic obsessive-compulsive disorder, stress, and wellbeing, together with supportive discussion and general problem-solving. The intervention does not include Exposure and Response Prevention, Habit Reversal Training, or other targeted behavioural techniques. Treatment is delivered individually over 12 weekly 50-minute sessions, either face-to-face or remotely.

Psychoeducation / Supportive Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • All genders
  • Confirmation of a primary diagnosis of either:
  • a. Tourettes Disorder / Tourette Syndrome b. Persistent Motor or Vocal Tic Disorder / Chronic Motor or Vocal Tic Disorder c. Provisional Tic Disorder / Transient Motor Tics d. Other Specified Tic Disorder e. Unspecified Tic Disorder f. Obsessive-Compulsive Disorder \[d\] Participants taking psychotropic medication are eligible provided medication type and dose remain stable throughout the intervention period \[e\] Ability to provide sustained informed consent \[f\] A minimum score of 16 on YBOCS \[g\] A minimum score of 5 on the Premonitory Urge for Tics Scale (PUTS)

You may not qualify if:

  • Substance misuse
  • Current diagnosis of a personality disorder
  • Schizophrenia
  • Bipolar disorder
  • Contraindications to participation in a trial (i.e., active suicidal ideations and/or requirement of an interpreter)
  • Any psychiatric or neurological condition that, in the opinion of the investigators, would interfere with participation or interpretation of study outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University College London Hospitals NHS Foundation Trust

London, London, WC1N 3BG, United Kingdom

RECRUITING

University College London Queen Square Institute of Neurology

London, London, WC1N 3BG, United Kingdom

RECRUITING

MeSH Terms

Conditions

Compulsive Personality DisorderTic DisordersTourette SyndromeObsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental DisordersMovement DisordersCentral Nervous System DiseasesNervous System DiseasesNeurodevelopmental DisordersBasal Ganglia DiseasesBrain DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAnxiety Disorders

Central Study Contacts

Dipesh Patel, MPhil / PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly allocated to one of four groups: (1) combined ERP and HbRT, (2) ERP alone, (3) HbRT alone, or (4) a supportive psychoeducation control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 24, 2026

Study Start

July 8, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

February 1, 2030

Last Updated

July 27, 2026

Record last verified: 2026-07

Locations